Path ID: DB06811_MESH_D014648_1
Concepts
| Identifier | Name | Type |
|---|---|---|
| MESH:C008976 | polidocanol | Drug |
| MESH:D012597 | Sclerosing Solutions | ChemicalSubstance |
| HP:0100699 | Scarring | PhenotypicFeature |
| GO:0097709 | connective tissue replacement | BiologicalProcess |
| HP:0002619 | Varicose veins | PhenotypicFeature |
| MESH:D014648 | Venous varices | Disease |
Relationships
NOTE: predicates are annotated in Biolink Model (v1.3.0)
| Subject | Predicate | Object |
|---|---|---|
| Polidocanol | CHEMICALLY SIMILAR TO | Sclerosing Solutions |
| Sclerosing Solutions | CAUSES | Scarring |
| Scarring | POSITIVELY CORRELATED WITH | Connective Tissue Replacement |
| Connective Tissue Replacement | NEGATIVELY CORRELATED WITH | Varicose Veins |
| Varicose Veins | MANIFESTATION OF | Venous Varices |
Comment: Polidocanol is a sclerosing agent indicated to treat uncomplicated spider veins. Sclerosing solutions cause the vein to scar, forcing blood to reroute through healthier veins. The collapsed vein is reabsorbed into local tissue and eventually fades (https://www.mayoclinic.org/tests-procedures/sclerotherapy/about/pac-20384592).
Reference: